SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " pharma " 699 found 🔀 AI-powered Shuffle
Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory
BMS enhances its AI computing power with NVIDIA's DGX SuperPOD as big pharma race to stay competitive within the shifting global landscape.
New UK PM shuts down science and tech department
In the midst of appointing his Cabinet, new UK Prime Minister Andy Burnham has scrapped the Department for Science, Innovation and Technology (DSIT).
Beyond weight loss: Lilly aims for leadership in brain science
Lilly’s neuroscience chief discusses the large pharma’s aims in brain science, and how diagnostics and dosing are driving its next advancements in Alzheimer’s.
Pet medications now available at CVS Pharmacy®
Pet owners can now fill eligible pet prescriptions at CVS Pharmacy locations nationwide, with convenient options including refills, prescription management and delivery.
Wooly Mammoth startup Colossal seeking at least $20B valuation
Its research could be foundational in pharmaceuticals, climate change reversal, and longevity.
Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin
The pharmaceutical company has demonstrated how AI can transform how drugs discovery and is now scaling AI across R&D to accelerate the discovery of next-generation medicines.
Seven peptides are under review by an FDA panel this week. Here’s everything we know
The committee will discuss whether compounding pharmacies can make the peptides in question. But FDA scientists say there’s little — if any — evidence they work in humans.
Health tech firm Craneware says customer and staff data stolen in cyber attack
The Edinburgh-based company provides software to the US healthcare industry, including thousands of hospitals, clinics and pharmacies.
Delivering Access
There was once a time when you healthcare without mentioning Honeybee Health Inc. In 2019, CNBC listed it as one of the 100 most promising startups. In
Creative Life Science Showcases Regenerative Medicine Manufacturing Capabilities at BIO Asia–Taiwan 2026
Creative Life Science Showcases Regenerative Medicine Manufacturing Capabilities at BIO Asia–Taiwan 2026
The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and AtaiBeckley Inc. (Nasdaq: ATAI), a clinical-stage biopharmaceutical company developing innovative...
Eli Lilly is reinventing the pharma business
The world’s largest drugmaker is betting big on preventive medicines—and learning from big tech
New Alaska law will allow pharmacists to provide more healthcare
Lawmakers overrode a Gov. Dunleavy veto to pass a law that expands what pharmacists can do in the state. Experts say it will allow more Alaskans to access lifesaving care and medications for opioid use disorder.
5-year update: Food Pharmacy at UF Health Jacksonville sees results
Improving the lives of patients one bite at a time. That’s the goal of a food pharmacy at UF Health.
Vistria sells stake in specialty pharmacy company to Warburg Pincus
Revenue at the Pittsburgh, Penn.-based Pantherx Rare had grown to nearly $10 billion from $2 billion since Vistria's investment.
Anthropic's Claude Science could disrupt Kendall Square and biopharma
Few places on the planet have more at stake in AI’s transformation and disruption of life sciences than the Massachusetts biomedical ecosystem.
Germany pushes through healthcare reform package despite pharma's drug discount resistance
Even as the effort has met with fierce pushback from drugmakers, trade groups and opposition parties in the country’s own government, German lawmakers late Friday voted to pass health insurance ref | Even as the effort has met with fierce pushback, German lawmakers late Friday voted to pass health insurance reforms aiming to cut healthcare costs, in part by hiking up mandatory rebates that pharmas must pay on branded medicines.
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
/PRNewswire/ -- Servier, an independent international pharmaceutical group governed by a foundation, today announced that it has completed the acquisition of...
Pesticide makers stack wins against US environmental, public health groups
The U.S. Supreme Court handed a major legal victory to German agrichemical and pharmaceutical company Bayer last month when it reined in thousands of lawsuits accusing the German company of failing to warn users that glyphosate, the active ingredient in its Roundup weedkiller, causes cancer.
Who’s more to blame for frustration at the pharmacy—insurers changing formularies or prescribers failing to keep up?
Patients increasingly wait for—or never receive—drug treatments deemed appropriate and timely by their doctors.
Who’s more to blame for dashed ‘scrip’ fills—insurers restricting drug coverage or prescribers failing to keep up?
Patients increasingly wait for—or never receive—drug treatments deemed appropriate and timely by their doctors.
Health insurance giants are fighting efforts to break them up
UnitedHealth Group, CVS Health and Cigna are suing states over new laws targeting their pharmacy businesses.
Big Medicine threatens your wallet and your health. But there is a solution.
The Break Up Big Medicine Act has bipartisan support, and builds on new laws restricting pharmacy benefit managers.
NC’s State Health Plan switching who administers its members’ benefits, again
The State Health Plan announced who won its health and pharmacy benefits contracts.
Apollo inks €3B equity deal for stake in Bayer's contraceptives business
Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal
Bayer sells stake in contraceptives business to Apollo in €3bn financing deal
Sale will help German pharmaceuticals group to bolster its balance sheet after years of litigation over Roundup weedkiller
Applications for new Doctor of Medical Science program now open
Campbell University College of Pharmacy & Health Sciences is now accepting applications for its new Doctor of Medical Science (DMSc)… More on this post
Impressive growth of Eli Lilly's obesity business is coming from all over the world
Eli Lilly's international GLP-1 business is booming, giving investors another reason to stick with the stock.
HEALTH FIRST: Managing cardiac sarcoidosis and heart disease
Megan Clark, a clinical pharmacist practitioner with Novant Health’s Heart and Vascular Institute, was in the studio to discuss the disease and treatment options.
Health Insurance Giants Are Fighting Efforts to Break Them Up
UnitedHealth Group, CVS Health and Cigna are suing states over new laws targeting their pharmacy businesses.
Danielle DiBari, Senior Vice President of Business Operations, Chief Pharmacy Officer and Chief Procurement Officer named to Becker's 2026 "101 Hospital and Health system Chief Pharmacy Officers to Know" List
NYC Health + Hospitals announced that Danielle DiBari, Senior Vice President of Business Operations, Chief Pharmacy Officer and Chief Procurement Officer,
Research shows how behavioral science silently protects American consumers and patients
A new Proceedings of the National Academy of Sciences (PNAS) special feature highlights the critical role of behavioral and decision sciences in U.S. governance. The publications demonstrate how psychological ...
Vertex to buy Crinetics in $10 billion deal
Vertex Pharmaceuticals will buy Crinetics Pharmaceuticals for a total equity value of about $10 billion, the companies said on Monday.
Primus Mbawuike, M.D., Pharm.D., Joins UAMS Health Family Medical Center in Pine Bluff
Primus Mbawuike, M.D., Pharm.D., has joined the University of Arkansas for Medical Sciences (UAMS) Family Medical Center in Pine Bluff where he will offer comprehensive care for all ages with additional expertise in pharmacy.
AeroSafe Global turns sustainable healthcare logistics into a high-growth business
Rochester-based AeroSafe Global pioneers cold-chain-as-a-service, employing nearly 200 locally and operating in 80 countries with sustainable pharma logistics.
CVS Health Corporation (CVS) Shares Up Significantly After Jim Cramer Said He Was Looking For A Good Year
We recently published Jim Cramer’s Biggest Winners to Buy: Top 20 AI & Other Stocks He Got Right in 2026. CVS Health Corporation (NYSE:CVS) is one of the stocks discussed by Jim Cramer. Pharmaceutical retailer CVS Health Corporation (NYSE:CVS) has become one of Cramer’s top stocks in the sector. Throughout this year, the CNBC TV […]
State Street Health Care ETF Tops Invesco Pharma on Cost and Size
Compare sector breadth, yield, and recent performance as these two healthcare ETFs take different approaches to growth and income.
Xtalks Announces its Life Science Webinar Calendar for July 2026
Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!
Greenville pharmacy acquires Ballston Spa business
Kelly’s Pharmacy in Greenville has expanded into Saratoga County. According to an announcement made Wednesday, the pharmacy has acquired O’Brien Pharmacy in Ballston Spa.
How does Maryland stack up in preventing and prosecuting Medicaid fraud?
High-profile federal Medicaid fraud prosecutions, including the indictment of a Dundalk pharmacist, raised questions about how Maryland works to prevent and prosecute fraud.
Why you should wash new clothes before wearing; signs that you are aging well; effective leadership in health care; plus other stories with Vanderbilt Health sources
Jami Miller, MD, Professor of Clinical Dermatology, and David Gaston, MD, PhD, Assistant Professor of Pathology, Microbiology and Immunology, are quoted in a Southern Living piece about the importance of washing new clothes before wearing them. Dyes, chemicals, mold and bacteria are all potential troublemakers lurking around your new duds. Parul Goyal, MBBS, Associate Professor of Clinical Medicine, was quoted in a Huff Post story outlining signs that you are aging well. Tae Kon Kim, MD, PhD, Assistant Professor of Medicine, was interviewed by Healio for a story headlined, “Effective leadership in health care ‘starts with listening.’” AAMC News reporter Patrick Boyle interviewed Wes Ely, MD, Professor of Medicine and Critical Care, for a story about ICU delirium. PharmaVoice reporter Kelly Bilodeau interviewed Romney Humphries, PhD, Vice Chair and Executive Medical Director, Clinical Services, for a story about the CDC’s new data that shows an alarming increase in the prevalence of a gene that can make “nightmare bacteria” significantly harder to treat. American Community Media interviewed William Schaffner, MD, Professor of Preventive Medicine, for a piece about Ebola that was reused by several media outlets around the U.S., including The Mississippi Link. Stacie Dusetzina, PhD, Professor of Health Policy, was quoted by The Independent in a story about how Medicare will soon cover weight-loss drugs. Courtney Schadt, MD, Associate Professor of Dermatology, was interviewed by Tennessean reporter Beth Warren, about tanning safety and tanning fads circulating social media. WKRN News 2 interviewed Amanda Peltier, MD, Professor of Neurology, about the correlation between head trauma and ALS following the diagnosis of former Titans running back Chris Johnson.
The future of Oxford: Science, technology, and collaboration
In conversation with Professor Lady Sue Black and Simon Ruck about Oxford North, from opening to today.
UToledo Health Pharmacy Residency Program Awarded Competitive National Grant
A $25,000 ASHP Foundation grant will grow UToledo's PGY1 Pharmacy Residency Program to seven residents, helping meet growing demand for pharmacist-led patient care.
Summer travel health: tips for heat exhaustion, insect bites and travel vaccines
Stay healthy while traveling with help from CVS Pharmacy and MinuteClinic. Get vaccines, refill prescriptions and prepare for summer travel risks.
PwC predicts: Providers, payers, pharma, medtech—all will have new to-do lists after the midterm elections. And that’s regardless of results.
With Election Day only four months away, healthcare is again emerging as a major source of idealistic campaign promises. Many of these are driven by widespread public angst. What sorts of changes can U.S. healthcare stakeholders realistically expect once the results are in?
Trinity Health Grand Rapids works to offer more free medication
Trinity Health Grand Rapids is rolling out a new program that aims to get prescription medicine to some of the lowest-income patients in West Michigan.
Anthropic debuts AI-driven pharma R&D tool, Claude Science
Anthropic launches Claude Science as big tech companies increasingly eye expansion in the wider healthcare and life sciences space.
Anthropic launches Claude Science for pharma researchers
Anthropic had made a big life sciences play with the launch of Claude Science, an AI 'workbench' for researchers involved in drug discovery.
Anthropic Launches Claude Science to Court Pharma Ahead of IPO
Anthropic unveiled Claude Science, an AI workbench designed to run — not just assist with — pharma research. The company is seeking to build out its customer base in the pharma sector as it deepens its healthcare push ahead of a widely anticipated IPO.
Anthropic unveils drug discovery plans alongside Claude Science, an AI tool for drugmakers
At an event on Tuesday, the AI heavyweight said it plans to target "neglected" diseases.
Anthropic releases Claude Science, a product aimed at researchers, the pharma industry
Anthropic released Claude Science, an application that optimizes its large language model for scientists and, especially, those doing research at pharma companies.
Reaching communities close to hostilities in Ukraine
Primary health care teams in Ukraine are reaching 121 locations within 60 km from active hostilities. This is part of the largest primary health care intervention in frontline areas in the country. European Union (EU)-supported teams are delivering essential services to people trapped by constant shelling and severe security constraints in 7 regions where no pharmacies operate, no health facilities function and evacuation remains impossible for residents.
Klick Health Acquires Oxford PharmaGenesis, Bringing Together Unsurpassed Scientific-to-Commercial Capabilities for Life Sciences Clients
Focused on taking life sciences companies into the future, Klick Health today announced its acquisition of Oxford PharmaGenesis, the market-leading HealthSci...
Peptides are the latest US health craze. But what exactly are they?
While peptides are taking the health and wellness category by storm for various use cases, what exactly are they? Leerink Partners senior research analyst Michael Cherny helps break down what a peptides are, how people are choosing them for personal health and recovery reasons, and who the biggest winners in consumer pharmaceuticals could be if their popularity continues to grow.
Indy economic development leaders visiting Switzerland on trade trip
The trip will involve meetings with leaders in the life sciences, biotechnology and pharmaceuticals, medical technology, digital heath and advanced manufacturing sectors.
Databricks and Nvidia Launch Genesis Workbench for AI Scientists
AI is becoming an increasingly important tool for drug discovery. However, for many pharmaceutical and biotech companies, the challenge isn’t finding more powerful models. It’s getting existing models to work […]
Expanding pharmacists’ authority is about healthcare
Alaska’s passage of House Bill 195 marks a practical and overdue step toward improving access to healthcare, especially in a state where geography alone can turn a minor illness into
Life Science Reagent Market Forecast Points Higher Toward 2035, Driven by Biopharma Scale-Up and Cell Therapy Expansion
World life science reagent market forecast 2026-2035: CAGR 6-8%, index 2035=185. Bioprocessing, cell therapy, and QC drive growth. Key players: Thermo Fisher, Merck, Danaher.
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Positive results from the MULBERRY Phase III trial showed that efzimfotase alfa (ALXN1850), an investigational enzyme replacement therapy, demonstrated a statistically significant and clinically meaningful improvement in bone health in children (2 to
States seek to lower drug prices by targeting the companies that manage them for health plans
TOPEKA, Kan. — As consumers worry about medication costs, states are trying to lower drug prices by reining in big companies that oversee prescription coverage for health insurers. Some of those companies, called pharmacy benefit managers, also own pharmacies, and one of them, CVS, has spent millions of dollars fighting
Tired of long waits? Mochi Health offers virtual care starting at $39
Mochi Health now offers full-service virtual care with unlimited visits, flexible pharmacy options and plans starting as low as $39.
Scientists measure hidden quantum forces that could power a new generation of pharmaceutical drugs
It's one thing to design a pharmaceutical drug. It's another to know if and why it actually works; not on paper or in a computer model, but inside the chaotic world of living systems, where proteins twist ...
Following IAM Union Advocacy, Kansas PERB Orders Count of Timely Cast Ballots in KU Health System Pharmacy Technician Union Election
KANSAS CITY, Kan. — Following weeks of advocacy from the IAM Union, Pharmacy Technicians, elected officials and community supporters, the Kansas Public Employee Relations Board (PERB) has ruled that 37 previously uncounted ballots will be included in the final tally of the recent union representation election involving Pharmacy Technicians at the University of Kansas (KU)
Q&A: What does science say about plants as medicine?
Plants have always played an integral role in traditional medicine and healing practices, according to Kent Vrana, Elliot S. Vesell Professor of Pharmacology at Penn State College of Medicine…
Merck KGaA bolsters life sciences business with $11.3B Bio-Techne buy
The deal comes a matter of weeks after Kai Beckmann was promoted to CEO at Merck and signalled his intent to broaden the company's scope for M&A.
Scientists measure hidden quantum forces that could power a new generation of pharmaceutical drugs
Researchers invent a laser technique that reveals the hidden forces shaping proteins, advancing a future of precision medicine engineered with quantum precision.
Merck Expands Life Science Leadership with Planned $11.3 Billion Bio-Techne Acquisition
Merck Expands Life Science Leadership with Planned $11.3 Billion Bio-Techne Acquisition
This health data provider could benefit as AI reshapes drug research
Harvey Stober, senior equity analyst and correspondent at CNBC, explains why this healthcare company could benefit from artificial intelligence reshaping the drug industry thanks to its treasure trove of data.
Florida Attorney General Issues Subpoena to CVS Health in Pharmacy Probe
Florida’s attorney general says he is examining whether CVS’s pharmacy benefit manager steers patients to its own pharmacies.
Florida AG launches investigation into CVS Health over pharmacy competition concerns
Florida Attorney General James Uthmeier issued a Civil Investigative Demand to CVS Health Corporation, the owner of the Caremark pharmacy benefit manager and hundreds of CVS retail pharmacies across the state.
Holland & Knight Health Dose: June 23, 2026 | Insights
The Centers for Medicare & Medicaid Services CMS issued a request for information RFI seeking input on implementation of new requirements for pharmacy benefit managers PBMs.
CVS Pharmacy® expands GLP-1 support to lower costs, improve access, and help patients stay on therapy
New $50 monthly copay for eligible Medicare patients, one-on-one pharmacist guidance, and over-the-counter products to help manage common side effects available to support patients
Scott Lowe, researcher: ‘Governments must fund science. Pharmaceutical companies want to help, but they also want to make money’
The geneticist speaks with EL PAÍS about the advances and challenges in the field of cancer research
Balancing benefit and risk: Nisha Vora on the science of pharmacovigilance
As Safety Science Director, she works across both early development and post-marketing, ensuring that risks are anticipated, analyzed, and managed so treatments can reach patients responsibly.
Major grocery operator on the hook for $40M over pharmacy monkey business; $6M windfall for whistleblower
One of the largest food retailers in the world—and the fourth biggest in this country—got itself into hot water with the U.S. Department of Justice for allegedly cheating on drug prices it charges to federal healthcare programs.
UToledo Pharmacy and Science Career Camp
University of Toledo Medical Center hosted a Pharmacy and Science Career Camp during which 47 students from five different states were introduced to potential careers.
Q&A: What does science say about plants as medicine?
Plants have always played an integral role in traditional medicine and healing practices, according to Kent Vrana, Elliot S. Vesell Professor of Pharmacology at Penn State College of Medicine, and they ...
Abarca Health and LucyRx Announce Strategic Combination to Create the Only Modern PBM Built for Commercial and Government Scale
Abarca Health and LucyRx today announced a strategic combination to create the only modern, independent pharmacy benefit manager with the scale, technology, and track record to credibly serve commercial and government clients of any size. Combined, Abarca and LucyRx will provide prescription services to more than 9 million members across the United States.
Abarca Health And LucyRx To Merge Into Alternative To Big Three PBMs
Abarca Health and LucyRx - two independent pharmacy benefit managers - have agreed to merge asregulators and the public seek a better price on prescription drugs.
USF names new dean of the Taneja College of Pharmacy
Janice Zgibor has been appointed as the new dean of the USF Health Taneja College of Pharmacy. A pharmacist and epidemiologist, Zgibor has served at USF for more than a decade and brings over 20 years of academic leadership experience to the role.She will become just the second permanent dean of the college.
KU Health System Pharmacy Technicians Hold Rally to Demand Every Union Election Vote Be Counted
KU Health System has not yet agreed that all timely postmarked ballots in closely contested union elections be counted. KANSAS CITY, Kan. — Pharmacy Technicians at The University of Kansas (KU) Health System held a rally to demand that every timely cast ballot be counted in their union election and to call attention to the
Q&A: What does science say about plants as medicine?
Plants have always played an integral role in traditional medicine and healing practices. In this Q&A, Kent Vrana, Elliot S. Vesell Professor of Pharmacology and director of the Center for Cannabis and Natural Product Pharmaceutics at Penn State College of Medicine, discussed the relationship is between plant science and human health and the growing role of plant-derived solutions in medicine.
Our New Study Shows That The Science Of Cannabis And Sleep Extends Beyond THC (Op-Ed)
“We found that the strongest evidence for improving sleep was associated with cannabidiol (CBD), cannabinol (CBN) and combinations of the two—but not primarily THC.” By Andrea Efre, University of South Florida College of Nursing The cannabis sleep market represents a shift away from traditional pharmaceuticals toward a natural alternative. Historically, cannabis products marketed for sleep […]
Express Scripts sues Tennessee over PBM law that would close specialty pharmacy
The company called the state’s regulation of pharmacy benefit managers “shortsighted,” as it would force the closure of Accredo, a specialty drug dispensary that supplies drugs it says aren’t available anywhere else in the state.
Rejuvenate Bio and Merck Animal Health Join Forces on Novel Animal Health Gene Therapy Programme
Rejuvenate Bio and Merck Animal Health Join Forces on Novel Animal Health Gene Therapy Programme
Mizuho Raises CVS Health (CVS) Price Target on More Stable Policy Environment
With an annual dividend yield of 2.65%, CVS Health Corporation (NYSE:CVS) is included among the 12 High Yield Fortune 500 Stocks to Buy Now. America’s leading health solutions company, CVS Health Corporation (NYSE:CVS), provides advanced health care from pharmacy services and health plans to health and wellness. On June 8, Mizuho upped its price target on […]
ECRD 2026: Europe’s rare disease bottleneck is funding rather than science
Derisking assets to attract capital and rethinking funding models should be key priorities for Europe to retain its research pipeline.
Using AI for medical advice; pelvic floor exercises; the hidden dangers of burning incense; plus other stories with Vanderbilt Health sources
Colin Walsh, MD,Associate Professor of Biomedical Informatics, was on WTVF News Channel 5‘s “Morningline” show in an interview about whether or not it is safe to use AI for medical advice. Time magazine reporter Stacey Colino interviewed Elisabeth Sebesta, MD, Assistant Professor of Urology, for a story about pelvic floor exercises for issues including menopause, erectile dysfunction and urinary incontinence in men. “Each Breath,” published by the American Lung Association, quoted Brian Christman, MD, Adjunct Professor of Medicine, for a story about the hidden dangers of burning incense. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: Healthline (low vaccination rates lead to more cases of measles, whooping cough and other preventable diseases); ABC News (U.S. measles cases surpass 2,000 for second year in a row); and CIDRAP News (high-dose flu shots cut rates of hospitalization in older adults). Sarah Rohde, MD, Associate Professor of Otolaryngology-Head and Neck Surgery, was quoted in a People magazine story on patient Makalii Andrade, a surfer from Kauai Island who suffered a serious neck injury in 2022 and recently underwent surgery at Vanderbilt Health to begin the final phase of his recovery. James Crowe, MD, Director of the Vanderbilt Center for Antibody Therapeutics, for a piece in Nature about antibodies against a strain of Ebola. SFGATE reporter Gillian Mohney interviewed Xue Zhong, PhD, Research Assistant Professor, Division of Genetic Medicine and Clinical Pharmacology, for a story about a study of a blood test looking at Alzheimer’s disease biomarkers. Matthew Franklin Mart, MD, Assistant Professor of Medicine, was quoted in a Healio story about how inflammation and illness severity is linked to less cognitive resilience after a person has been an ICU patient. The “How We Really Feel” podcast host Sula Windgassen, PhD, interviewed Lindsey C. McKernan, PhD, MPH, Associate Professor of Psychiatry & Behavioral Sciences, Physical Medicine & Rehabilitation and Urology, for an episode focusing on pelvic and bladder health. The podcast is also available on YouTube and the podcast website. In addition, podcaster Monica Sanford interviewed cardiologist Mark Glazer, MD, for her podcast “The Monica Sanford Show”; the two-part interview is here and here.
Bayer appoints Reinhard to president of radiology business
Bayer announced that Dr. Jost Reinhard will be appointed president of the radiology business within Bayer’s Pharmaceuticals Division.
Astronauts Could Grow Their Own Medicines in Space Using Plants
The pharmaceutical cabinet of the future might look a lot like a garden.
Business Restructuring Review Vol. 25 No. 3 May-June 2026
In This Issue Texas Bankruptcy Court Adopts Barnet Rule Requiring Foreign Debtor to Have U.S. Assets to Be Eligible for Chapter 15 Relief In In re Siu-Fung Ceramics Holdings Limited, No. 24-33299, 2026 WL 382424 (Bankr. S.D. Tex. Feb. 10, 2026), the court denied petitions for chapter 15 recognition of Hong Kong bankruptcy and liquidation proceedings commenced on behalf of an individual debtor and a group of companies that he owned or controlled. According to the court: (i) the corporate debtors' Hong Kong liquidation proceeding was not eligible for chapter 15 recognition because the attorney retainer upon which such relief was based was not funded until nine months after the chapter 15 petition date; and (ii) the individual debtor's Hong Kong bankruptcy case could not be recognized because the debtor's "center of main interests" on the chapter 15 petition date was not in Hong Kong, and he did not even maintain an "establishment" there. [read more …] Southern District of Texas Clarifies Post-Purdue Course for Consensual Third-Party Releases and Gatekeeping Provisions In In re Container Store Group, Inc., 676 B.R. 356 (S.D. Tex. 2026), appeal filed, No. 26-20166 (5th Cir. Apr. 14, 2026), cross appeal filed, No. 26-20166 (5th Cir. Apr. 24, 2026), the U.S. District Court for the Southern District of Texas addressed consensual third-party releases and gatekeeping provisions in the aftermath of the U.S. Supreme Court's ruling in Harrington v. Purdue Pharma L.P., 603 U.S. 204 (2024). Consistent with existing Fifth Circuit precedent, the court confirmed that, in appropriate circumstances, consent for third-party releases may be obtained through a creditor's failure to opt out of granting that consent. But, the court ruled, consent through an opt-out mechanism essentially can never be inferred for creditor classes that stand to receive no recovery under a chapter 11 plan and that are deemed to reject the plan by operation of applicable bankruptcy law. Instead, those classes must affirmatively opt in to any release. The court also narrowed and remanded the bankruptcy court's acceptance of a broad gatekeeping provision, ruling that such provisions must correspond to the restrictions established by Fifth Circuit precedent. [read more …] Delaware Bankruptcy Court: Initial Transferee Need Not Be Defendant in Fraudulent Transfer Avoidance and Recovery Litigation The Bankruptcy Code gives a bankruptcy trustee the power to avoid asset transfers that are either made with the intent to defraud creditors or that are "constructively" fraudulent because an insolvent debtor did not receive adequate value in exchange. The Bankruptcy Code also permits recovery of an avoided transfer from not only the initial recipient, but also from subsequent transferees. Courts disagree over whether a transfer must actually be avoided before the trustee can seek recovery from a subsequent transferee and whether the initial transferee must also be a defendant in the recovery litigation against a subsequent transferee. The U.S. Bankruptcy Court for the District of Delaware weighed in on this debate in Phillips v. SS Associates LLC (In re ONH AFC CS Investors, LLC), No. 23-10931 (CTG), 2026 WL 312892 (Bankr. D. Del. Feb. 4, 2026). The court adopted the majority view, ruling that the initial transferee need not be a defendant in avoidance and recovery litigation against a subsequent transferee, but that the trustee must establish the elements necessary to avoid the initial transfer as part of the recovery litigation. [read more …] New York Bankruptcy Court Weighs In on Adequate Assurance of Future Performance under Assigned Leases and Chapter 11 Plan Exculpation Provisions In order to assume and assign an executory contract or unexpired lease, a bankruptcy trustee must cure most defaults under the agreement and provide "adequate assurance" of the assignee's future performance. However, the Bankruptcy Code provides no guidance as to the meaning of "adequate assurance" other than with respect to shopping center leases. In In re Broadway Realty I Co. LLC, No. 25-11050, 2026 WL 147505 (Bankr. S.D.N.Y. Jan. 19, 2026), the U.S. Bankruptcy Court for the Southern District of New York examined this issue in connection with a proposed assignment of thousands of residential leases as part of a free-and-clear sale of debtors' properties. The court held that "adequate assurance" does not mean a guarantee of the assignee's future performance, but merely demonstration that the assignee has the ability to satisfy the underlying obligations. The bankruptcy court also ruled that an exculpation provision in the debtors' chapter 11 plan exonerating non-estate fiduciaries from liability for actions taken in connection with the chapter 11 case was unobjectionable, provided it was limited in scope to postpetition conduct and actions taken in connection with implementation of the plan after its effective date. [read more …] Newsworthy Corinne Ball (New York) (Hall of Fame), Bruce Bennett (Los Angeles), Carl E. Black (Cleveland), Jeffrey B. Ellman (Atlanta), Brad B. Erens (Chicago), Gregory M. Gordon (Dallas), Heather Lennox (Cleveland/New York), Joshua M. Mester (Los Angeles), and Kevyn D. Orr (Washington) were included in the 2026 edition of Lawdragon 500 Leading Bankruptcy and Restructuring Lawyers. The Daily Business Review selected Isel M. Perez (Miami) as an "On the Rise" winner for the Florida Legal Awards. The Florida Legal Awards annually recognize those who have made significant contributions to the legal industry in Florida. Dan T. Moss (Washington/New York) was inducted as a Fellow in the 37th Class of the American College of Bankruptcy at its Annual Meeting in March 2026 in San Antonio, Texas. Christine Borries (Munich) was ranked in the practice area Restructuring/Insolvency in the 2026 edition of Chambers Germany. The 2027 edition of The Best Lawyers in Singapore™ recognized Sushma Jobanputra (Singapore) in the practice area Insolvency & Reorganization. The restructuring transaction involving Eissmann Automotive North America, Inc. received the "2025 Turnaround of the Year (Large Company)" at the Turnaround Management Association (Detroit) Annual Awards Reception. T. Daniel Reynolds (Cleveland) and Nick Buchta (Cleveland) represented subsidiaries of Eissmann Group Automotive in connection with the parent company's German insolvency proceedings. Roger Dobson (Sydney) is among 40 Jones Day lawyers recognized by The Best Lawyers in Australia 2027 for his contributions in Banking and Finance Law; Distressed Investing & Debt Trading; Insolvency and Reorganization Law; Litigation. An article written by Corinne Ball (New York) titled "Ard Finance—A Global Enterprise Combining an LME With a Foreign Insolvency Proceeding and Chapter 15" was published in the April 21, 2026, edition of the New York Law Journal. An article written by Alex Sapp (New York) titled "Recent Developments in Section 510—Subordination" was published in the 2025 edition of the Norton Annual Survey on Bankruptcy Law. An article written by Brad B. Erens (Chicago) titled "New York Bankruptcy Court Approves Insider DIP Litigation Financing" was published on April 6, 2026, by Lexis Practical Guidance. An article written by Corinne Ball (New York), Dan T. Moss (Washington/New York), David S. Torborg (Washington), and Isel M. Perez (Miami) titled "New York District Court Affirms Narrow Scope of 'Public Policy Exception' in Chapter 15 Cases" was published on April 6, 2026, by Lexis Practical Guidance. An article written by Jeffrey B. Ellman (Atlanta) titled "Statutory Cap on Lease Rejection Damage Claims in Bankruptcy Applies to Solvent Debtors" was published on April 6, 2026, by Lexis Practical Guidance. An article written by Trisha L. Mowbray (Real Estate; Chicago) and Ryan Sims (Washington) titled "Chapter 11 Plan that Abridged Non-Debtor Lessee's Rights to Remain in Possession After Rejection Unconfirmable as Having Been Proposed in Bad Faith" was published on April 6, 2026, by Lexis Practical Guidance. Lawyer Spotlight: Ben Rosenblum Ben Rosenblum, a partner in the New York Office, represents debtors, creditors, and other parties in out-of-court restructurings and court-supervised proceedings, including chapter 11 cases, municipal bankruptcies, international insolvency matters, and stockbroker liquidations. His experience spans industries such as manufacturing, shipping, mining, aviation, energy, real estate, and telecommunications. Ben's notable debtor representations include Peabody Energy, the City of Detroit, Chrysler LLC, Spansion Japan, and Dana Corporation. Significant creditor representations include General Maritime Corporation, Calpine Corporation, American Home Mortgage, and Murray Energy. He currently represents creditors in Puerto Rico's restructuring. He also has extensive experience advising financial institutions on bankruptcy law as applied to derivatives.
U of A dismantles Health Sciences unit, disperses functions university-wide
University of Arizona Health Sciences — which has housed the colleges of medicine in Tucson and Phoenix, and the colleges of nursing, pharmacy and public health — is being dismantled
U of A dismantles Health Sciences unit, disperses functions university-wide
University of Arizona Health Sciences — which has housed the colleges of medicine in Tucson and Phoenix, and the colleges of nursing, pharmacy and public health — is being dismantled
Mark Nelson, Ph.D., Elected to the UK’s Academy of Medical Sciences
Mark Nelson, Ph.D., University Distinguished Professor and chair of pharmacology at the Robert Larner, M.D. College of Medicine at the University of Vermont, has been named a 2026 Fellow of the Academy of Medical Sciences.
Allegheny County’s Sexual Health Clinic moves Downtown
The Allegheny County Health Department has relocated its Sexual Health Clinic to Downtown Pittsburgh, consolidating services in one location to make it easier for patients to access sexual health care, immunizations, pulmonary services and public health pharmacy resources. The department announced the move Monday, saying the new site provides a
US: Global Health Aid Tied to Harmful Conditions
The United States government is conditioning lifesaving health assistance on broad access to surveillance data and extractive rights to pathogen samples and data for pharmaceutical development.
Scientists achieve the first total synthesis of a complex alkaloids isolated from plant
Monoterpenoid indole alkaloids (MIAs) are plant-derived molecules with unique pharmaceutical potential, but their highly complex and intricate structures make them difficult to produce in the laboratory. Now, researchers from Japan have developed a new strategy that enables the total synthesis of bisleuconothine A and bousigonine B, two biologically relevant oligomeric MIAs. Their findings lay the foundation for further studies of this family of molecules. Monoterpenoid indole alkaloids (MIAs) are plant-derived molecules with unique pharmaceutical potential, but their highly complex and intricate structures make them difficult to produce in the laboratory. Now, researchers from Japan have developed a new strategy that enables the total synthesis of bisleuconothine A and bousigonine B, two biologically relevant oligomeric MIAs. Their findings lay the foundation for further studies of this family of molecules.
U.S. Supreme Court sides with generic drug maker for severe hypertriglyceridemia agent icosapent ethyl
The decision clears the way for Hikma Pharmaceuticals' sale of icosapent ethyl in the U.S. market.